Skip to main content
Premium Trial:

Request an Annual Quote

UK s MRC Gets Access to Celera s Discovery System

NEW YORK, Feb. 1 - Celera Genomics has licensed Discovery System to the United Kingdom Medical Research Council, the company said on Thursday.


The multi-year deal makes Celera's database available to a consortium of UK academic researchers.

The agreement is administered by the MRC but is open to all UK-based academic researchers, Celera said.


Financial terms of the agreement were not disclosed.  

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.